Table 3.
Prevalence of latex sensitization and allergy in the general pediatric population and those exposed to risk factors.
Studied Population | Latex Allergy | Sensitization to Latex | Country | Author, Year | Ref. |
---|---|---|---|---|---|
General Population | 4.3% | 2.1% | Worldide | Wu, 2016 | [8] |
Patients with spina bifida | 46% | - | Singapore | Chua, 2013 | [13] |
47.9% | Germany | Cremer, 2011 | [11] | ||
37% | 55% | Germany | Blumchen, 2010 | [12] | |
26.7% | Spain | Nieto, 2002 | [10] | ||
Patients with spina bifida operated in a latex-free environment | 4.5% | Spain | Nieto, 2002 | [10] | |
0.8% | 5% | Germany | Blumchen, 2010 | [12] | |
Patients with myelomeningocele | 20% | 25% | Brazil | Bueno de Sa, 2013 | [5] |
19.5% | - | Spain | Parisi, 2016 | [9] | |
Atopic Patients | 2.6% | 3.9% | Italy | Meglio, 2002 | [26] |
0.5% | 3.8% | Portugal | Jorge, 2006 | [27] | |
2.7% | 4% | Egypt | El-Sayed, 2014 | [28] |